vs
亚什兰（ASH）与FMC CORP（FMC）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是亚什兰的2.0倍（$759.0M vs $386.0M），亚什兰净利率更高（-3.1% vs -37.0%，领先33.9%），FMC CORP同比增速更快（-4.0% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $-628.1M），过去两年FMC CORP的营收复合增速更高（-14.5% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
ASH vs FMC — 直观对比
营收规模更大
FMC
是对方的2.0倍
$386.0M
营收增速更快
FMC
高出0.6%
-4.7%
净利率更高
ASH
高出33.9%
-37.0%
自由现金流更多
ASH
多$739.1M
$-628.1M
两年增速更快
FMC
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $759.0M |
| 净利润 | $-12.0M | $-281.2M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | -10.6% |
| 净利率 | -3.1% | -37.0% |
| 营收同比 | -4.7% | -4.0% |
| 净利润同比 | 92.7% | — |
| 每股收益（稀释后） | $-0.26 | $-2.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHFMC
| Q1 26 | — | $759.0M | ||
| Q4 25 | $386.0M | $1.1B | ||
| Q3 25 | $477.0M | $542.2M | ||
| Q2 25 | $463.0M | $1.1B | ||
| Q1 25 | $479.0M | $791.4M | ||
| Q4 24 | $405.0M | $1.2B | ||
| Q3 24 | $521.0M | $1.1B | ||
| Q2 24 | $544.0M | $1.0B |
净利润ASHFMC
| Q1 26 | — | $-281.2M | ||
| Q4 25 | $-12.0M | $-1.7B | ||
| Q3 25 | $31.0M | $-569.3M | ||
| Q2 25 | $-742.0M | $66.7M | ||
| Q1 25 | $31.0M | $-15.5M | ||
| Q4 24 | $-165.0M | $-16.3M | ||
| Q3 24 | $17.0M | $65.0M | ||
| Q2 24 | $6.0M | $295.1M |
毛利率ASHFMC
| Q1 26 | — | — | ||
| Q4 25 | 27.2% | 39.8% | ||
| Q3 25 | 33.3% | 23.8% | ||
| Q2 25 | 28.5% | 38.7% | ||
| Q1 25 | 30.7% | 40.0% | ||
| Q4 24 | 27.4% | 42.9% | ||
| Q3 24 | 33.2% | 36.3% | ||
| Q2 24 | 34.2% | 38.3% |
营业利润率ASHFMC
| Q1 26 | — | -10.6% | ||
| Q4 25 | -1.6% | -130.8% | ||
| Q3 25 | 12.8% | -73.1% | ||
| Q2 25 | -152.9% | 12.0% | ||
| Q1 25 | 10.6% | 7.4% | ||
| Q4 24 | -44.2% | 19.2% | ||
| Q3 24 | 6.1% | 12.7% | ||
| Q2 24 | -11.2% | 6.0% |
净利率ASHFMC
| Q1 26 | — | -37.0% | ||
| Q4 25 | -3.1% | -158.8% | ||
| Q3 25 | 6.5% | -105.0% | ||
| Q2 25 | -160.3% | 6.3% | ||
| Q1 25 | 6.5% | -2.0% | ||
| Q4 24 | -40.7% | -1.3% | ||
| Q3 24 | 3.3% | 6.1% | ||
| Q2 24 | 1.1% | 28.4% |
每股收益（稀释后）ASHFMC
| Q1 26 | — | $-2.25 | ||
| Q4 25 | $-0.26 | $-13.77 | ||
| Q3 25 | $0.83 | $-4.52 | ||
| Q2 25 | $-16.21 | $0.53 | ||
| Q1 25 | $0.65 | $-0.12 | ||
| Q4 24 | $-3.50 | $-0.13 | ||
| Q3 24 | $0.34 | $0.52 | ||
| Q2 24 | $0.12 | $2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $390.9M |
| 总债务越低越好 | $1.4B | $2.8B |
| 股东权益账面价值 | $1.9B | $1.8B |
| 总资产 | $4.5B | $9.4B |
| 负债/权益比越低杠杆越低 | 0.74× | 1.50× |
8季度趋势，按日历期对齐
现金及短期投资ASHFMC
| Q1 26 | — | $390.9M | ||
| Q4 25 | $304.0M | $584.5M | ||
| Q3 25 | $215.0M | $497.7M | ||
| Q2 25 | $207.0M | $438.2M | ||
| Q1 25 | $168.0M | $315.3M | ||
| Q4 24 | $219.0M | $357.3M | ||
| Q3 24 | $300.0M | $416.7M | ||
| Q2 24 | $399.0M | $471.5M |
总债务ASHFMC
| Q1 26 | — | $2.8B | ||
| Q4 25 | $1.4B | $3.4B | ||
| Q3 25 | $1.4B | $3.4B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.1B | ||
| Q4 24 | $1.3B | $3.1B | ||
| Q3 24 | $1.3B | $3.1B | ||
| Q2 24 | $1.3B | $3.1B |
股东权益ASHFMC
| Q1 26 | — | $1.8B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.9B | $3.8B | ||
| Q2 25 | $1.9B | $4.4B | ||
| Q1 25 | $2.6B | $4.4B | ||
| Q4 24 | $2.6B | $4.5B | ||
| Q3 24 | $2.9B | $4.6B | ||
| Q2 24 | $3.0B | $4.6B |
总资产ASHFMC
| Q1 26 | — | $9.4B | ||
| Q4 25 | $4.5B | $9.7B | ||
| Q3 25 | $4.6B | $12.1B | ||
| Q2 25 | $4.6B | $12.3B | ||
| Q1 25 | $5.2B | $11.8B | ||
| Q4 24 | $5.2B | $11.7B | ||
| Q3 24 | $5.6B | $12.2B | ||
| Q2 24 | $5.7B | $12.1B |
负债/权益比ASHFMC
| Q1 26 | — | 1.50× | ||
| Q4 25 | 0.74× | 1.62× | ||
| Q3 25 | 0.73× | 0.89× | ||
| Q2 25 | 0.73× | 0.76× | ||
| Q1 25 | 0.52× | 0.71× | ||
| Q4 24 | 0.51× | 0.69× | ||
| Q3 24 | 0.47× | 0.68× | ||
| Q2 24 | 0.45× | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | — |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $-628.1M |
| 自由现金流率自由现金流/营收 | 28.8% | -82.8% |
| 资本支出强度资本支出/营收 | 3.6% | 2.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $-154.0M |
8季度趋势，按日历期对齐
经营现金流ASHFMC
| Q1 26 | — | — | ||
| Q4 25 | $125.0M | $657.1M | ||
| Q3 25 | $40.0M | $-184.2M | ||
| Q2 25 | $115.0M | $65.9M | ||
| Q1 25 | $9.0M | $-545.0M | ||
| Q4 24 | $-30.0M | $427.9M | ||
| Q3 24 | $80.0M | $159.5M | ||
| Q2 24 | $127.0M | $292.2M |
自由现金流ASHFMC
| Q1 26 | — | $-628.1M | ||
| Q4 25 | $111.0M | $631.1M | ||
| Q3 25 | $6.0M | $-207.9M | ||
| Q2 25 | $95.0M | $50.9M | ||
| Q1 25 | $-12.0M | $-576.6M | ||
| Q4 24 | $-53.0M | $406.3M | ||
| Q3 24 | $42.0M | $143.8M | ||
| Q2 24 | $98.0M | $282.3M |
自由现金流率ASHFMC
| Q1 26 | — | -82.8% | ||
| Q4 25 | 28.8% | 58.3% | ||
| Q3 25 | 1.3% | -38.3% | ||
| Q2 25 | 20.5% | 4.8% | ||
| Q1 25 | -2.5% | -72.9% | ||
| Q4 24 | -13.1% | 33.2% | ||
| Q3 24 | 8.1% | 13.5% | ||
| Q2 24 | 18.0% | 27.2% |
资本支出强度ASHFMC
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.6% | 2.4% | ||
| Q3 25 | 7.1% | 4.4% | ||
| Q2 25 | 4.3% | 1.4% | ||
| Q1 25 | 4.4% | 4.0% | ||
| Q4 24 | 5.7% | 1.8% | ||
| Q3 24 | 7.3% | 1.5% | ||
| Q2 24 | 5.3% | 1.0% |
现金转化率ASHFMC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | 2.45× | ||
| Q2 24 | 21.17× | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
FMC
| EMEA | $307.0M | 40% |
| North America | $198.0M | 26% |
| Latin America | $177.0M | 23% |
| Asia (excluding 2026 India) 1 | $81.0M | 11% |
